Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Arthritis, Rheumatoid × Etanercept × Clear all

Phase

Phase 4 9 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Psoriasis 3 Lymphoma, Follicular 3 Uveitis 1 Pruritus 1 Pneumonia 1 Plaque, Amyloid 1 Cachexia 1 Bronchiolitis Obliterans Syndrome 1 Arthritis, Rheumatoid 1 Arthritis, Juvenile 1 Anorexia 1

Interventions

Methotrexate 4 Abatacept 3 tocilizumab 2 Rituximab 2 tofacitinib 1 secukinumab 1 olokizumab 1 golimumab 1 baricitinib 1 Radioimmunodetection 1 RC-18 1 Etanercept 1 Double-Blind Method 1 Certolizumab Pegol 1 Antirheumatic Agents 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00357903 2017-02-09

Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trials

Amgen

Phase 3 Completed

639 enrolled 27 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡